Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Conceptus reports clinical advances with S/TOP system

Aug. 16, 1996

Zonagen initiates pivotal trials of Vasomax

Aug. 16, 1996

Andropatch marketed in U.K.

Aug. 16, 1996

BASF to manufacture Ares-Serono's hGH

Aug. 16, 1996

Antidiabetic potential of CDP-571 assessed, rejected in human trials

Aug. 16, 1996

Antidiabetic efficacy of ABB demonstrated in rats

Aug. 16, 1996

TheraTech studies oral mucosal delivery system for GLP-1

Aug. 16, 1996

Beta3 agonists reported by Dainippon

Aug. 16, 1996

GW-5823: CCK-A agonist for treatment of obesity

Aug. 16, 1996

ImmuCell, Agri-Mark establish lactoferrin JV

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.